XML 97 R84.htm IDEA: XBRL DOCUMENT v3.21.2
Segment Information (Schedule of Business Segments) (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Segment Reporting Information [Line Items]          
Net sales $ 2,266 $ 1,411 $ 6,262 $ 4,064  
Other (charges) gains, net (Note 14) 0 (10) 3 (37)  
Operating profit (loss) 536 184 1,429 461  
Equity in net earnings (loss) of affiliates 44 25 110 113  
Depreciation and amortization 93 89 274 261  
Capital expenditures 123 [1] 76 [1] 309 [2] 242 [2]  
Goodwill and intangible assets, net 1,434   1,434   $ 1,485
Total assets 11,583   11,583   10,909
Increase (decrease) in accrued capital expenditures 21 4 5 (37)  
Acetate Tow          
Segment Reporting Information [Line Items]          
Net sales 128 129 385 385  
Acetyl Chain          
Segment Reporting Information [Line Items]          
Net sales [3] 1,454 756 3,866 2,170  
Engineered Materials          
Segment Reporting Information [Line Items]          
Net sales 684 526 2,011 1,509  
Operating Segments [Member] | Acetate Tow          
Segment Reporting Information [Line Items]          
Net sales 128 129 385 385  
Other (charges) gains, net (Note 14) 0 0 0 (1)  
Operating profit (loss) 12 30 52 88  
Equity in net earnings (loss) of affiliates 0 0 0 0  
Depreciation and amortization 10 9 29 26  
Capital expenditures 10 10 31 26  
Goodwill and intangible assets, net 154   154   154
Total assets 1,088   1,088   975
Operating Segments [Member] | Acetyl Chain          
Segment Reporting Information [Line Items]          
Net sales 1,489 776 3,954 2,237  
Other (charges) gains, net (Note 14) 1 1 1 6  
Operating profit (loss) 517 121 1,284 377  
Equity in net earnings (loss) of affiliates 1 2 5 3  
Depreciation and amortization 44 41 128 122  
Capital expenditures 73 37 171 118  
Goodwill and intangible assets, net 286   286   301
Total assets 4,327   4,327   3,930
Operating Segments [Member] | Engineered Materials          
Segment Reporting Information [Line Items]          
Net sales 684 526 2,011 1,509  
Other (charges) gains, net (Note 14) 0 (10) 6 (35)  
Operating profit (loss) 91 84 344 173  
Equity in net earnings (loss) of affiliates 39 21 96 100  
Depreciation and amortization 35 34 105 100  
Capital expenditures 36 21 92 73  
Goodwill and intangible assets, net 994   994   1,030
Total assets 4,205   4,205   3,990
Corporate, Non-Segment [Member] | Other          
Segment Reporting Information [Line Items]          
Net sales 0 0 0 0  
Other (charges) gains, net (Note 14) (1) (1) (4) (7)  
Operating profit (loss) (84) (51) (251) (177)  
Equity in net earnings (loss) of affiliates 4 2 9 10  
Depreciation and amortization 4 5 12 13  
Capital expenditures 4 8 15 25  
Goodwill and intangible assets, net 0   0   0
Total assets 1,963   1,963   2,014
Eliminations [Member]          
Segment Reporting Information [Line Items]          
Net sales (35) [4] (20) [4] (88) [5] (67) [5]  
Other (charges) gains, net (Note 14) 0 0 0 0  
Operating profit (loss) 0 0 0 0  
Equity in net earnings (loss) of affiliates 0 0 0 0  
Depreciation and amortization 0 0 0 0  
Capital expenditures 0 0 0 0  
Goodwill and intangible assets, net 0   0   0
Total assets 0   0   $ 0
Eliminations [Member] | Acetyl Chain          
Segment Reporting Information [Line Items]          
Net sales $ 35 $ 20 $ 88 $ 67  
[1] Includes an increase in accrued capital expenditures of $21 million and $4 million for the three months ended September 30, 2021 and 2020, respectively.
[2] Includes an increase in accrued capital expenditures of $5 million and a decrease of $37 million for the nine months ended September 30, 2021 and 2020, respectively.
[3] Excludes intersegment sales of $35 million and $20 million for the three months ended September 30, 2021 and 2020, respectively. Excludes intersegment sales of $88 million and $67 million for the nine months ended September 30, 2021 and 2020, respectively.
[4] Includes intersegment sales primarily related to the Acetyl Chain.
[5] Includes intersegment sales primarily related to the Acetyl Chain.